Año: 2023
Journal Impact Factor (JIF): 2.50
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| CLINICAL NEUROLOGY | ESCI | 130/280 | Q2 | T2 | D5 |
Año: 2021
Journal Citation Indicator (JCI): 0,390
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| CLINICAL NEUROLOGY | 214/267 | Q4 | T3 | D8 | 20,04 |
Año:
2023
CiteScore:
4,000
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 156/387 | Q2 | T2 | D5 |
SJR año:
2024
Factor de Impacto:
0,705
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Neurology (clinical) | 194/406 | Q2 | T2 | D5 |
| Agencia | Código de Proyecto |
|---|---|
| Abbott | - |
| Abbvie | - |
| Abide Therapeutics | - |
| Academy for Healthcare Learning | - |
| Acadia | - |
| Actelion | - |
| Allergan | - |
| Almirall Hermal GmbH | - |
| American Academy of Neurology | - |
| Aptinyx | - |
| Arizona Alzheimer's Consortium | - |
| Axovant | - |
| Bachmann-Strauss Foundation | - |
| Biogen | - |
| Boston Scientific | - |
| CHDI, Damp-Stiftung (Kiel, Germany) | - |
| Deutsche Forschungsgemeinschaft (DFG) | 396914663; 396577296; 396474989 |
| DFG | GZ MU 1527/3-1; GZ MU 1527/3-2; BMBF: 01KG1421 |
| DOD | - |
| Dystonia Coalition | - |
| Dystonia Medical Research Foundation | - |
| Dystonia Medical Research Foundation Canada | - |
| Einstein | - |
| Eisai | - |
| Eli Lilly | - |
| EU | 278367; 316978 |
| European Reference Network -Rare Neurological Diseases (ERN -RND) | 739510 |
| European Union | 01492947 |
| Freigeist Fellowship of the VolkswagenStiftung | - |
| GW pharmaceuticals | - |
| Henry Stewart | - |
| Interessenverband Tourette Syndrom (Germany) | - |
| Ipsen | - |
| Ipsen Corporate | - |
| Margot und Jurgen Wessel Stiftung (Lubeck, Germany) | - |
| Medicus | - |
| MedNet | - |
| Medtronic | - |
| Medtronic, Inc. | - |
| Merz | - |
| Merz Pharmaceuticals | - |
| Michael J Fox Foundation | - |
| Michael J. Fox Foundation | - |
| Michael P Smith Family | - |
| Movement Disorders Society | - |
| National Institute of Mental Health (NIMH) | - |
| Neuraly | - |
| Neurocrine | - |
| Neuroderm | - |
| NIH | R01 NR014852; R01NS096008; R25NS108939 |
| NIH (NIMH) | - |
| Nuvelution | - |
| Owerko Foundation | - |
| Parkinson Alliance | - |
| Parkinson Canada | - |
| Parkinson Foundation | - |
| Parkinson's Foundation | - |
| PeerView | - |
| Possehl-Stiftung (Lubeck, Germany) | - |
| Prilenia | - |
| province of Friesland | - |
| Public Health Agency of Canada and Alberta Health | - |
| QuantiaMD | - |
| Revance | - |
| Smallwood Foundation | - |
| Stichting Wetenschapsfonds Dystonie Vereniging | - |
| Teva | - |
| Therapix Biosiences | - |
| Theravance | - |
| Tourette Association | - |
| Tourette Association of America | - |
| Tourette Gesellschaft Deutschland e.V. Else-Kroner-Fresenius-Stiftung | - |
| Tourette Syndrome Association | - |
| Tourette Syndrome Association (Germany) | - |
| UF Foundation | - |
| Vanderbilt University | - |
| WebMD/Medscape | - |
| ZONMW-TOP | 91218013 |
| # | Autor |
|---|---|
| 1 | |
| 2 | Sarva, H. |
| 3 | Kurvits, L. |
| 4 | Gilbert, D. L. |
| 5 | Hartmann, A. |
| 6 | Worbe, Y. |
| 7 | Mir, P. |
| 8 | Muller-Vahl, K. R. |
| 9 | Munchau, A. |
| 10 | Shprecher, D. |
| 11 | Singer, H. S. |
| 12 | Deeb, W. |
| 13 | Okun, M. S. |
| 14 | Malaty, I. A. |
| 15 | Hallett, M. |
| 16 | Tijssen, M. A. |
| 17 | Pringsheim, T. |
| 18 | Martino, D. |
